Ticker
IRMDCompany Name
IRADIMED CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 106.45M | $ 53M | 49.79% |
3/31/2025 | $ 101.73M | $ 50.33M | 49.48% |
12/31/2024 | $ 98.33M | $ 52.23M | 53.12% |
9/30/2024 | $ 94.25M | $ 51.72M | 54.88% |
6/30/2024 | $ 89.95M | $ 48.54M | 53.96% |
3/31/2024 | $ 88.01M | $ 45.13M | 51.27% |
12/31/2023 | $ 92.16M | $ 49.76M | 54% |
9/30/2023 | $ 87.41M | $ 46.75M | 53.48% |
6/30/2023 | $ 81.43M | $ 45.82M | 56.27% |
3/31/2023 | $ 75.62M | $ 42.78M | 56.57% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for IRADIMED CORP is calculated as follows: CashnEq [ $ 47.55M ] / Assets [ $ 70.43M ]
(=) Cash to Assets [ 67.52% ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |